Franklin Biotechnology Discovery Fund
Filed by Franklin Strategic Series. What this fund reported holding in its latest quarterly NPORT-P. Positions are ordered by share of the fund rather than by size, because that is what separates a conviction from a rounding error.
What it holds
Largest share of the fund first.
| Company | % of fund | Value |
|---|---|---|
| AMGNAmgen Inc | 4.39% | $50.7M |
| GILDGilead Sciences, Inc | 3.86% | $44.5M |
| REGNRegeneron Pharmaceuticals Inc | 3.77% | $43.5M |
| ARGXargenx SE | 3.62% | $41.8M |
| VRTXVertex Pharmaceuticals Inc | 3.54% | $40.8M |
| GHGuardant Health Inc | 2.76% | $31.8M |
| INSMInsmed Inc | 1.99% | $23M |
| PRAXPraxis Precision Medicines Inc | 1.91% | $22.1M |
| NBIXNeurocrine Biosciences Inc | 1.82% | $21M |
| BBIOBridgeBio Pharma Inc | 1.67% | $19.3M |
| AMLXAmylyx Pharmaceuticals Inc | 1.32% | $15.3M |
| LLYEli Lilly and Co | 1.31% | $15.1M |
| CYTKCytokinetics Inc | 1.24% | $14.3M |
| ARQTArcutis Biotherapeutics Inc | 1.18% | $13.6M |
| TMOThermo Fisher Scientific Inc | 1.14% | $13.2M |
| IONSIonis Pharmaceuticals Inc | 0.94% | $10.8M |
| ALNYAlnylam Pharmaceuticals Inc | 0.91% | $10.5M |
| PCVXVaxcyte Inc | 0.68% | $7.9M |
| RLAYRelay Therapeutics Inc | 0.66% | $7.6M |
| BNTXBiontech SE | 0.58% | $6.6M |
| KRYSKrystal Biotech Inc | 0.43% | $5M |
| GPCRStructure Therapeutics Inc | 0.42% | $4.9M |
| RLMDRelmada Therapeutics Inc | 0.36% | $4.2M |
| COGTCogent Biosciences Inc | 0.26% | $3M |
| RAREUltragenyx Pharmaceutical Inc | 0.23% | $2.7M |
Source: NPORT-P filings, via EDGAR. Positions arrive by CUSIP, and only a CUSIP verified against a ticker is kept — so this is what we could match, not everything the fund holds, and the matched value is therefore below the fund's own size. A balance is shares where the filing says `NS` and a principal amount where it says `PA`, which is why it is not labelled shares in both cases.
Follow Franklin Biotechnology Discovery Fund by email
Franklin Biotechnology Discovery Fund's new holdings reports, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.